Historical Valuation
Organogenesis Holdings Inc (ORGO) is now in the Fair zone, suggesting that its current forward PS ratio of 1.09 is considered Fairly compared with the five-year average of 35.24. The fair price of Organogenesis Holdings Inc (ORGO) is between 2.19 to 10.49 according to relative valuation methord.
Relative Value
Fair Zone
2.19-10.49
Current Price：4.21
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Organogenesis Holdings Inc (ORGO) has a current Price-to-Book (P/B) ratio of 2.31. Compared to its 3-year average P/B ratio of 1.69 , the current P/B ratio is approximately 36.26% higher. Relative to its 5-year average P/B ratio of 3.87, the current P/B ratio is about -40.40% higher. Organogenesis Holdings Inc (ORGO) has a Forward Free Cash Flow (FCF) yield of approximately -8.78%. Compared to its 3-year average FCF yield of -1.91%, the current FCF yield is approximately 359.01% lower. Relative to its 5-year average FCF yield of -0.31% , the current FCF yield is about 2751.47% lower.
P/B
Median3y
1.69
Median5y
3.87
FCF Yield
Median3y
-1.91
Median5y
-0.31
Competitors Valuation Multiple
AI Analysis for ORGO
The average P/S ratio for ORGO competitors is 1.38, providing a benchmark for relative valuation. Organogenesis Holdings Inc Corp (ORGO.O) exhibits a P/S ratio of 1.09, which is -21.53% above the industry average. Given its robust revenue growth of 30.98%, this premium appears sustainable.
Performance Decomposition
AI Analysis for ORGO
1Y
3Y
5Y
Market capitalization of ORGO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ORGO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ORGO currently overvalued or undervalued?
Organogenesis Holdings Inc (ORGO) is now in the Fair zone, suggesting that its current forward PS ratio of 1.09 is considered Fairly compared with the five-year average of 35.24. The fair price of Organogenesis Holdings Inc (ORGO) is between 2.19 to 10.49 according to relative valuation methord.
What is Organogenesis Holdings Inc (ORGO) fair value?
ORGO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Organogenesis Holdings Inc (ORGO) is between 2.19 to 10.49 according to relative valuation methord.
How does ORGO's valuation metrics compare to the industry average?
The average P/S ratio for ORGO's competitors is 1.38, providing a benchmark for relative valuation. Organogenesis Holdings Inc Corp (ORGO) exhibits a P/S ratio of 1.09, which is -21.53% above the industry average. Given its robust revenue growth of 30.98%, this premium appears sustainable.
What is the current P/B ratio for Organogenesis Holdings Inc (ORGO) as of Jan 10 2026?
As of Jan 10 2026, Organogenesis Holdings Inc (ORGO) has a P/B ratio of 2.31. This indicates that the market values ORGO at 2.31 times its book value.
What is the current FCF Yield for Organogenesis Holdings Inc (ORGO) as of Jan 10 2026?
As of Jan 10 2026, Organogenesis Holdings Inc (ORGO) has a FCF Yield of -8.78%. This means that for every dollar of Organogenesis Holdings Inc’s market capitalization, the company generates -8.78 cents in free cash flow.
What is the current Forward P/E ratio for Organogenesis Holdings Inc (ORGO) as of Jan 10 2026?
As of Jan 10 2026, Organogenesis Holdings Inc (ORGO) has a Forward P/E ratio of 22.07. This means the market is willing to pay $22.07 for every dollar of Organogenesis Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Organogenesis Holdings Inc (ORGO) as of Jan 10 2026?
As of Jan 10 2026, Organogenesis Holdings Inc (ORGO) has a Forward P/S ratio of 1.09. This means the market is valuing ORGO at $1.09 for every dollar of expected revenue over the next 12 months.